ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP PRSYM
    • 2016-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • Register
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstract Number: 57

Quantification of Dynamic MRI examinations in Juvenile Idiopathic Arthritis

Nikolay Tzaribachev1, Romiesa Hagoug2, Polymnia Louka3, Joyee Islam3, Mark Hinton3, Olga Kubassova4 and Mikael Boesen5, 1PRI - Pediatric Rheumatology Research Institute, Bad Bramstedt, Germany, 2Imaging, Image Analysis Group, London, United Kingdom, 3Image Analysis Group, London, United Kingdom, 4Image Analysis Group, Image Analysis Group, London, England, 5Radiology, Copenhagen University Hospital, Bispebjerg and Frederiksberg, Frederiskberg, Denmark

Meeting: 2017 Pediatric Rheumatology Symposium

Keywords: Biomarkers, Juvenile idiopathic arthritis (JIA) and outcomes, MRI

  • Tweet
  • Email
  • Print
Save to PDF
Session Information

Date: Thursday, May 18, 2017

Session Title: Clinical and Therapeutic Poster Session

Session Type: Abstract Submissions

Session Time: 5:30PM-7:00PM

Background/Purpose: In chronic inflammatory conditions, the need for a more objective measurement of disease activity has been identified, where dynamic contrast enhanced (DCE) MRI as imaging biomarker has been studied in RA. In children with juvenile idiopathic arthritis (JIA) similar knowledge is very limited. The purpose was to compare treatment related changes of clinical scores in patients with JIA and automated DCE-MRI quantitative parameters analyzed with a dedicated software Dynamikatm also compared to clinical outcomes of the patients.

Methods: In patients with polyarticular JIA with insufficient (≥3 affected joints) response or intolerance to ≥3 months Methotrexate, Etanercept was started. Six Slice Axial DCE-MRI of the metacarpophaleangeal (MCP) 2-5 joints in the clinically most affected hand was performed at 3 time points: baseline (BL), month 3 and 6 of treatment using a 0.2 Tesla Esaote C-Scan. Clinical scores included active joint (AJ) counts. Clinical response was considered a state of ≤ 3 AJ. DCE-MRI was analyzed using regions of interest (ROI) covering synovium in slices where MCPs 2-5 were visible. Output parameters included dynamic MRI quantification scores (DEMRIQvol) corresponding to the volume of enhancing voxels within the synovial ROIs alone or multiplied with the mean of the maximum enhancement (ME) or the initial rate of enhancement (IRE) .

Differences in DEMRIQvol scores between visits were analyzed using t-test (p<0.05* = statistically significant, p<0.25** = clinically meaningful). Concordance between clinical and DEMRIQvol scores were described.

Results: 18 Caucasian patients (12 girls, median age 12,6 years, median disease duration 1,2 years) were included in the study. Two patients discontinued imaging after BL but continued treatment. In all but 3 of the remaining patients statistically significant and/or clinically meaningful changes were documented for DEMRIQ ME between visits.

In 4 patients clinical and DEMRIQvol scores showed corresponded changes. In all other patients clinical and DEMRIQvol scores were non-concordant.

Based on DEMRIQvol change (irrespective of the clinical scores) the outcome of the patient could be predicted:

  • in 5 patients improvement of DEMRIQvol scores predicted response to treatment (within 2-6 months after last MRI examination)
  • in 4 patients an increase or persistence of a high DEMRIQvol predicted non-response to treatment
  • in 7 patients increase in DEMRIQvol (after initial decrease) or persistence of a high DEMRIQvol predicted flare (in 3 of the patients flare occurred after treatment discontinuation)

In all patients subclinical disease could be detected on MRI in clinically unaffected joints.

Conclusion: Dynamika based scores appear to be useful for depicting disease activity in JIA and seem to support clinical examination by detecting subclinical inflammation. More over, in the present study DEMRIQvol scores were predictive for the outcome of the patients and were able to “foresee” response to treatment, flare of disease, non-response to treatment in most patients possibly making DEMRIQvol scores supportive in research and clinical decision taking.



Disclosure: N. Tzaribachev, None; R. Hagoug, 3; P. Louka, 3; J. Islam, 3; M. Hinton, 3; O. Kubassova, 3; M. Boesen, 6.

To cite this abstract in AMA style:

Tzaribachev N, Hagoug R, Louka P, Islam J, Hinton M, Kubassova O, Boesen M. Quantification of Dynamic MRI examinations in Juvenile Idiopathic Arthritis [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 4). https://acrabstracts.org/abstract/quantification-of-dynamic-mri-examinations-in-juvenile-idiopathic-arthritis/. Accessed April 13, 2021.
  • Tweet
  • Email
  • Print
Save to PDF

« Back to 2017 Pediatric Rheumatology Symposium

ACR Meeting Abstracts - https://acrabstracts.org/abstract/quantification-of-dynamic-mri-examinations-in-juvenile-idiopathic-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Convergence: Where Rheumatology Meets. All Virtual. November 5-9.

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2021 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.